122 related articles for article (PubMed ID: 31803765)
1. Microtubule-Associated Protein 2 Expression in Canine Glioma.
Demeter EA; Frank C; Rissi DR; Porter BF; Miller AD
Front Vet Sci; 2019; 6():395. PubMed ID: 31803765
[TBL] [Abstract][Full Text] [Related]
2. Canine Gliomatosis Cerebri: Morphologic and Immunohistochemical Characterization Is Supportive of Glial Histogenesis.
Rissi DR; Donovan TA; Porter BF; Frank C; Miller AD
Vet Pathol; 2021 Mar; 58(2):293-304. PubMed ID: 33357125
[TBL] [Abstract][Full Text] [Related]
3. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells.
Blümcke I; Becker AJ; Normann S; Hans V; Riederer BM; Krajewski S; Wiestler OD; Reifenberger G
J Neuropathol Exp Neurol; 2001 Oct; 60(10):984-93. PubMed ID: 11589429
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of neural stem cell lineage markers in canine brains, gliomas, and a glioma cell line.
Yoshida K; Chambers JK; Uchida K
Vet Pathol; 2023 Jan; 60(1):35-46. PubMed ID: 36384382
[TBL] [Abstract][Full Text] [Related]
5. EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.
Burel-Vandenbos F; Benchetrit M; Miquel C; Fontaine D; Auvergne R; Lebrun-Frenay C; Cardot-Leccia N; Michiels JF; Paquis-Flucklinger V; Virolle T
J Neurooncol; 2011 Apr; 102(2):171-8. PubMed ID: 20652725
[TBL] [Abstract][Full Text] [Related]
6. Doublecortin immunolabeling and lack of neuronal nuclear protein immunolabeling in feline gliomas.
Elbert JA; Rissi DR
J Vet Diagn Invest; 2022 Jul; 34(4):757-760. PubMed ID: 35678136
[TBL] [Abstract][Full Text] [Related]
7. OLIG2 immunolabeling in feline ependymoma.
Demeter EA; Kent M; Glass EN; Rissi DR; Edwards J; Miller AD
J Vet Diagn Invest; 2022 Sep; 34(5):898-901. PubMed ID: 35762120
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analyses of neural stem cell lineage markers in normal feline brains and glial tumors.
Yoshida K; Chambers JK; Nibe K; Kagawa Y; Uchida K
Vet Pathol; 2024 Jan; 61(1):46-57. PubMed ID: 37358305
[TBL] [Abstract][Full Text] [Related]
9. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
[TBL] [Abstract][Full Text] [Related]
10. MAP2 IHC detection: a marker of antigenicity in CNS tissues.
D'Andrea MR; Howanski RJ; Saller CF
Biotech Histochem; 2017; 92(5):363-373. PubMed ID: 28766965
[TBL] [Abstract][Full Text] [Related]
11. GFAP-positive neoplastic astrocytes in spontaneous oligodendrogliomas and mixed gliomas of rats.
Nagatani M; Yamakawa S; Saito T; Ando R; Hoshiya T; Tamura K; Uchida K
Toxicol Pathol; 2013; 41(4):653-61. PubMed ID: 23076037
[TBL] [Abstract][Full Text] [Related]
12. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
13. Presence of neural progenitors in spontaneous canine gliomas: A histopathological and immunohistochemical study of 20 cases.
Fernández F; Deviers A; Dally C; Mogicato G; Delverdier M; Cauzinille L; Gnirs K; Añor S; de la Fuente C; Fondevila D; Pumarola M
Vet J; 2016 Mar; 209():125-32. PubMed ID: 26831167
[TBL] [Abstract][Full Text] [Related]
14. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
[TBL] [Abstract][Full Text] [Related]
15. In vitro identification and functional characterization of glial precursor cells in human gliomas.
Colin C; Baeza N; Tong S; Bouvier C; Quilichini B; Durbec P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):189-202. PubMed ID: 16599947
[TBL] [Abstract][Full Text] [Related]
16. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors.
Blümcke I; Müller S; Buslei R; Riederer BM; Wiestler OD
Acta Neuropathol; 2004 Aug; 108(2):89-96. PubMed ID: 15146346
[TBL] [Abstract][Full Text] [Related]
17. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification.
Mokhtari K; Paris S; Aguirre-Cruz L; Privat N; Crinière E; Marie Y; Hauw JJ; Kujas M; Rowitch D; Hoang-Xuan K; Delattre JY; Sanson M
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):62-9. PubMed ID: 15634232
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of tissue factor, fibrin/fibrinogen and D-dimers in canine gliomas.
de la Fuente C; Pumarola M; Blasco E; Fernández F; Viu J; Añor S
Vet J; 2014 Jun; 200(3):387-92. PubMed ID: 24745770
[TBL] [Abstract][Full Text] [Related]
19. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
20. Doublecortin immunolabeling in canine gliomas with distinct degrees of tumor infiltration.
Reyes VAA; Donovan TA; Miller AD; Porter BF; Frank CB; Rissi DR
J Vet Diagn Invest; 2023 Mar; 35(2):187-192. PubMed ID: 36522858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
